Pediatric Lymphoma

Pediatric lymphoma, or lymphoma in children, is not clinically distinct from lymphoma in adults but it is always especially difficult when a child cancer and specialized treatment may be necessary. There are also certain types of lymphoma that are more prevalent in children.

The following are summaries of the most common pediatric lymphomas. Please click on the blue titles to read more about each subject.

Pediatric Hodgkin's Lymphoma

Cancer continues to be the leading cause of death in children younger than 15 years old, and lymphomas are among the most common cancers seen in children. Fortunately, survival rates for childhood cancers have increased significantly over the years. Children respond to and deal with chemotherapy better than adults. Today, 96% of children diagnosed with Hodgkin's disease will survive 5 or more years, and 5-year survival rates are 86% for children diagnosed with non-Hodgkin's lymphoma (American Cancer Society, 2009).

Pediatric non-Hodgkin's Lymphoma

The third most common childhood cancer is lymphoma; it accounts for 10% of all childhood cancer diagnoses. Of these diagnoses, about 60% are Non-Hodgkin’s Lymphomas. Children are vulnerable to the same types of lymphoma as adults. Although diagnosis of lymphoma in a child is especially traumatic for everyone involved, it must be remembered that younger patients generally have higher recovery rates than adults.

Burkitt's Lymphoma

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children. In fact, it accounts for 30-40% of childhood lymphomas each year. Its cause is linked to the Epstein-Barr virus (EBV), which is also known as mononucleosis, though not all patients diagnosed with Burkitt's lymphoma have EBV.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap